These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5430846)

  • 1. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
    Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T
    Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
    Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
    Savenkov PM; Segal' RG
    Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic agents for lipid metabolism disorders--with special reference to fatty liver].
    Okabe K; Fujisawa K; Takahashi T
    Nihon Rinsho; 1970 Mar; 28():Suppl:700-3. PubMed ID: 5465060
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the antilipidogenic and hypolipidemic effects of Insoal in diabetics and atherosclerotics].
    Warembourg H; Jaillard J
    Lille Med; 1967 May; 12(4):Suppl:510-5. PubMed ID: 5619704
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S; Esilä R; Tuovinen E
    Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic influence on the blood lipids in manifest coronary sclerosis].
    Aschenbeck G
    Rev Bras Med; 1971 Dec; 28(12):653-8. PubMed ID: 4259647
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 13. New trends in lipid management: eight cases to consider.
    Smith DA
    Mt Sinai J Med; 2005 Mar; 72(2):90-9. PubMed ID: 15770338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of anabolic preparations in atherosclerotic cardiosclerosis].
    Agapova EN; Tkachenko AM; Krutovskaia OV
    Klin Med (Mosk); 1974 Jan; 52(1):42-4. PubMed ID: 4466884
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modification of lipid metabolism by anabolic agents].
    Fiegel G; Bargheer R; Kukwa D
    Arzneimittelforschung; 1966 Feb; 16(2):202-6. PubMed ID: 6014014
    [No Abstract]   [Full Text] [Related]  

  • 18. [The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis].
    Caruzzo C; Carnaghi R; Enrico-Bena L; De Marco G
    Minerva Med; 1969 Nov; 60(91):4514-8. PubMed ID: 5357297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 20. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.